323 related articles for article (PubMed ID: 33450819)
1. p53, A Victim of the Prion Fashion.
Billant O; Friocourt G; Roux P; Voisset C
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33450819
[TBL] [Abstract][Full Text] [Related]
2. Prion-like aggregation of mutant p53 in cancer.
Silva JL; De Moura Gallo CV; Costa DC; Rangel LP
Trends Biochem Sci; 2014 Jun; 39(6):260-7. PubMed ID: 24775734
[TBL] [Abstract][Full Text] [Related]
3. Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?
Costa DC; de Oliveira GA; Cino EA; Soares IN; Rangel LP; Silva JL
Cold Spring Harb Perspect Biol; 2016 Oct; 8(10):. PubMed ID: 27549118
[TBL] [Abstract][Full Text] [Related]
4. The aggregation of mutant p53 produces prion-like properties in cancer.
Rangel LP; Costa DC; Vieira TC; Silva JL
Prion; 2014; 8(1):75-84. PubMed ID: 24509441
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer.
Silva JL; Cino EA; Soares IN; Ferreira VF; A P de Oliveira G
Acc Chem Res; 2018 Jan; 51(1):181-190. PubMed ID: 29260852
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence of cellular transformation by prion-like p53 amyloid infection.
Navalkar A; Pandey S; Singh N; Patel K; Datta D; Mohanty B; Jadhav S; Chaudhari P; Maji SK
J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34085695
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor protein p53 expressed in yeast can remain diffuse, form a prion, or form unstable liquid-like droplets.
Park SK; Park S; Pentek C; Liebman SW
iScience; 2021 Jan; 24(1):102000. PubMed ID: 33490908
[TBL] [Abstract][Full Text] [Related]
8. p53 Aggregates penetrate cells and induce the co-aggregation of intracellular p53.
Forget KJ; Tremblay G; Roucou X
PLoS One; 2013; 8(7):e69242. PubMed ID: 23844254
[TBL] [Abstract][Full Text] [Related]
9. Prion-like p53 Amyloids in Cancer.
Navalkar A; Ghosh S; Pandey S; Paul A; Datta D; Maji SK
Biochemistry; 2020 Jan; 59(2):146-155. PubMed ID: 31603660
[TBL] [Abstract][Full Text] [Related]
10. Modulation of p53 and prion protein aggregation by RNA.
Cordeiro Y; Vieira T; Kovachev PS; Sanyal S; Silva JL
Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):933-940. PubMed ID: 30826454
[TBL] [Abstract][Full Text] [Related]
11. Prions, prion-like prionoids, and neurodegenerative disorders.
Verma A
Ann Indian Acad Neurol; 2016; 19(2):169-74. PubMed ID: 27293325
[TBL] [Abstract][Full Text] [Related]
12. The Contrived Mutant p53 Oncogene - Beyond Loss of Functions.
Sabapathy K
Front Oncol; 2015; 5():276. PubMed ID: 26697411
[TBL] [Abstract][Full Text] [Related]
13. Understanding the prion-like behavior of mutant p53 proteins in triple-negative breast cancer pathogenesis: The current therapeutic strategies and future directions.
Naeimzadeh Y; Tajbakhsh A; Fallahi J
Heliyon; 2024 Feb; 10(4):e26260. PubMed ID: 38390040
[TBL] [Abstract][Full Text] [Related]
14. p53 amyloid aggregation in cancer: function, mechanism, and therapy.
Li J; Guo M; Chen L; Chen Z; Fu Y; Chen Y
Exp Hematol Oncol; 2022 Sep; 11(1):66. PubMed ID: 36171607
[TBL] [Abstract][Full Text] [Related]
15. p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis.
Ghosh S; Salot S; Sengupta S; Navalkar A; Ghosh D; Jacob R; Das S; Kumar R; Jha NN; Sahay S; Mehra S; Mohite GM; Ghosh SK; Kombrabail M; Krishnamoorthy G; Chaudhari P; Maji SK
Cell Death Differ; 2017 Oct; 24(10):1784-1798. PubMed ID: 28644435
[TBL] [Abstract][Full Text] [Related]
16. Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.
de Oliveira GA; Rangel LP; Costa DC; Silva JL
Front Oncol; 2015; 5():97. PubMed ID: 25973395
[TBL] [Abstract][Full Text] [Related]
17. p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect.
Blagosklonny MV
FASEB J; 2000 Oct; 14(13):1901-7. PubMed ID: 11023974
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a Prion-Like Transmission of p53 Amyloid in Saccharomyces cerevisiae.
Sengupta S; Maji SK; Ghosh SK
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28630281
[TBL] [Abstract][Full Text] [Related]
19. Self-aggregation and coaggregation of the p53 core fragment with its aggregation gatekeeper variant.
Lei J; Qi R; Wei G; Nussinov R; Ma B
Phys Chem Chem Phys; 2016 Mar; 18(11):8098-107. PubMed ID: 26923710
[TBL] [Abstract][Full Text] [Related]
20. Role of p53 isoforms and aggregations in cancer.
Kim S; An SS
Medicine (Baltimore); 2016 Jun; 95(26):e3993. PubMed ID: 27368003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
